Description: | Hepatitis B Virus - Hepatitis B virus (HBV) is divided into four major serotypes (adr, adw, ayr, ayw) based on antigenic epitopes present on its envelope proteins and into eight genotypes (labeled A through H) according to overall nucleotide sequence variation of the genome. The genotypes have a distinct geographical distribution and are used in tracing the evolution and transmission of the virus. Differences between genotypes affect the disease severity, course and likelihood of complications and response to treatment and possibly vaccination. A possible new „I“ genotype has been described, but acceptance of this notation is not universal. Different genotypes may respond to treatment in different ways. HBV is one of a few known non-retroviral viruses which use reverse transcription as a part of its replication process. Hepatitis B is an infectious illness that infects the liver and causes an inflammation called hepatitis. Transmission of HBV results from exposure to infectious blood or body fluids such as semen and vaginal fluids, while viral DNA has been detected in the saliva, tears and urine of chronic carriers with high titer DNA in serum. Perinatal infection is a major route of infection in endemic countries. Other risk factors for developing HBV infection includes working in a health care setting, transfusions and dialysis. Acute infection with HBV is associated with acute viral hepatitis - an illness that begins with general ill-health, loss of appetite, nausea, vomiting, body aches, mild fever, dark urine and then progresses to development of jaundice. It has been noted that itchy skin has been an indication of a possible symptom of all hepatitis virus types. The illness lasts for a few weeks and then gradually improves in most affected people. A few patients may have more severe liver disease (fulminant hepatic failure) and may die as a result. The infection may be entirely asymptomatic and may go unrecognized. Chronic infection with HBV may be either asymptomatic or may be associated with a chronic inflammation of the liver, leading to cirrhosis over a period of several years. This type of infection dramatically increases the incidence of hepatocellular carcinoma. AmpliSens® HBV-FRT PCR kit is an in vitro nucleic acid amplification test for qualitative detection of hepatitis B virus (HBV) DNA in biological material (blood plasma) using real-time hybridization-fluorescence detection. |
Order #: | ECO-R-V5-MOD(RG,IQ,MX,DT)-CE |
Unit Size: | 112 |
Supplier: | Ecoli Dx |
Restrictions: | Only available in selected countries. |
Shipping: | See Manual |
Storage: | See Manual |
Subcategory: | PCR and Real-Time PCR Diagnostics |
More information: | Go to webpage |
Add to request list
- Phone: +49 (0)89 3799666-6
- E-mail: info@biozol.de
MoBiTec is now part of BIOZOL
All orders and requests placed via the online shop on www.mobitec.com are processed by BIOZOL Diagnostica Vertrieb GmbH.
You will receive an order confirmation by fax or e-mail. More information regarding the ordering process can be found here.
Technical Service - Product Information
Viewed